Focused ultrasound thalamotomy (FUS-T) was recently approved for the treatment of refractory essential tremor (ET). Despite its noninvasive approach, FUS-T reinitiated concerns about the adverse effects and long-term efficacy after lesioning. OBJECTIVE: To prospectively assess the outcomes of FUS-T in 10 ET patients using tractography-based targeting of the ventral intermediate nucleus (VIM). METHODS: VIM was identified at the intercommissural plane based on its neighboring tracts: the pyramidal tract and medial lemniscus. FUS-T was performed at the center of tractography-defined VIM. Tremor outcomes, at baseline and 3 mo, were assessed independently by the Tremor Research Group. We analyzed targeting coordinates, clinical outcomes, and adverse events. The FUS-T lesion location was analyzed in relation to unbiased thalamic parcellation using probabilisitic tractography. Quantitative diffusionweighted imaging changes were also studied in fiber tracts of interest.
centrally located deep brain structures, making it an ideal technology for ablative neurosurgery. 2 Focused ultrasound thalamotomy (FUS-T) became the first successful application for the treatment of refractory essential tremor (ET) and was recently approved by the United States Food and Drug Administration. 3 ET is the most common movement disorder with some studies suggesting prevalence estimates of 220 cases per 1000 persons. 4, 5 Although the first line pharmacotherapy, propanolol 6 and primidone, 7 provides some tremor control, the majority of patients eventually become medication refractory. 8 Deep brain stimulation (DBS) is considered the gold-standard surgical treatment for ET. 9 In a randomized comparison with radiofrequency thalamotomy, DBS had superior efficacy and better side effects profile. 10 Despite its proven effectiveness, only a minority of ET patients undergo DBS. 11 Most patients avoid DBS due to its invasive approach, and the need for implantable hardware. In this context, FUS-T may be a cost-effective option 12 for patients who are either not interested in undergoing DBS or not candidates for DBS. The major advantages of this technology include its noninvasive approach and immediate tremor reduction. In the pivotal, shamcontrolled, randomized trial, 13 the treatment cohort experienced 41% overall tremor reduction at 3 mo and 47% reduction in tremor on the treated hand coupled with a 46% improvement in the quality of life.
FUS-T, similar to radiofrequency thalamotomy, has 2 major limitations: 14 neurological deficits in immediate postprocedure phase and the loss of efficacy in long-term follow-up. In the pivotal study, 21 (out of 56) patients developed sensory deficits (persistent in 14 patients at year 1) and 2 patients developed motor deficits (persistent in 1 at year 1). 13 In addition, the efficacy reduced from 41% to 35% between 3-mo and 1-yr follow-ups. These limitations may be due to poor visualization of the ventral intermediate nucleus (VIM) and its surrounding tracts: pyramidal tract (PT), medial lemniscus (ML) and sensory thalamic nucleus (Vc) on structural MRI. 15 Given these imaging limitations, VIM is currently targeted using formulaic methods, and the final target is modified based on intraoperative testing of efficacy and side effects. 16 During FUS-T, the low-energy ultrasound (or "test sonication") is used to increase tissue temperatures to the sublesioning threshold (<45
• C) and produce transient clinical effects. Although these test sonications can be used to optimize the efficacy and safety of FUS-T, intraoperative clinical testing has known limitations, such as the DBS literature suggesting that intraoperative tremor reduction has poor predictive value for long-term tremor outcomes. 17 Furthermore, an increase in lesion size during therapeutic sonications (>55
• C) can inadvertently extend to the surrounding motor (PT) and sensory (ML and Vc) structures without an opportunity for course correction. Finally, additional testing and target optimization may increase operative times and potentially affect the tolerability of the FUS-T procedures and induce complications from prolonged immobilization like deep venous thrombosis. 18 Given these considerations, a tractography-based method for VIM targeting for stereotactic tremor surgery was developed. 19, 20 This approach involves delineating the anatomy relevant for tremor efficacy (VIM, dentatorubrothalamic tract [DRT] , and the thalamocortical projections) and side effect profile (PT, Vc, and ML). We report the short-term clinical results of the prospective VIM-region targeting with tractography in a cohort of essential tremor patients undergoing FUS-T as a part of the FDA continued access trial. We hypothesized that tractographybased targeting is safe and efficacious for VIM region targeting during FUS-T.
METHODS
This study was approved by the Institutional Review Board and all patients consented for the study. All successive patients with refractory, disabling ET were enrolled between July 2015-September 2016 at a single center. Patients were screened by a multidisciplinary team for the study inclusion and exclusion criteria. 21 A preoperative computerized tomographic scan was obtained to determine suitability of skull for the ultrasound treatment (determined by the skull density ratio ≥0.4). All patients underwent structural and diffusion-weighted imaging (DWI; 60 diffusion directions, 2-mm isovoxel) with a 3 Tesla MRI scanner (Philips Ingenia CX; Philips Inc, Amsterdam, The Netherlands). Images were processed with a clinically approved software platform (StealthViZ, Medtronic Inc, Minneapolis, MN). The diffusion direction data from the imaging protocol was incorporated in this software for imaging analysis. The detailed methodology for tractography-based VIM targeting is described previously. 19 After preprocessing, the lateral and posterior borders of the VIM were first defined by tracking the PT and ML, respectively, using standard tracking parameters (FA stop value = 0.2, seed density = 0.1, and tracking angle 45
• -60 • ; Figure 1 ). Identification of these tracts at the level of the intercommissural plane was considered crucial for the avoidance of side effects (ie motor weakness and paresthesias/sensory deficits). In the next step, a VIM region of interest (ROI) was placed at a distance of 3 mm each from PT and ML at the intercommissural level. The z-plane was predetermined in the intercommissural plane because it commonly coincides with the ventral border of thalamus. The size of this ROI was similar to the dimensions of human VIM nucleus (4 × 4 × 6 mm). The structural connectivity of this VIM ROI was then delineated and confirmed to the ipsilateral motor cortex (M1) and both ipsilateral and contralateral cerebellum (dentate nucleus). A DICOM overlay object was created in the center voxel of the ROI to be exported to the stereotactic targeting software (Framelink, Medtronic Inc). The target coordinates in relation to the posterior commissure (PC) and the lateral ventricular wall were noted.
On the day of treatment, the patient's head was shaved and the stereotactic head frame was placed. After acquiring structural images, the coordinates of the center of the tractography-based VIM ROI at the intercommissural plane were selected as the initial target for sonication. Sonications were performed under live thermography and clinical feedback from the awake patient. Clinical efficacy was assessed with a modified tremor scale intraoperatively. Subthreshold sonications (<45
• C) were first performed to assess the clinical efficacy and detect any potential side effects from the involvement of the sensory thalamus or PT. This also allowed for confirmation of targeting accuracy. The power was subsequently increased to achieve therapeutic temperature (>55
• C). A 50% decrease in intraoperative tremor score without side effects following a therapeutic sonication (>55
• C for 10 s duration) was chosen as a criterion for accurate VIM localization. Two or 3 therapeutic sonications at the target were considered as treatment endpoint.
Data Collection and Analysis
The tractography-based VIM coordinates were compared with the formulaic method 22 (X = 11 mm from the wall of the third ventricle,
FIGURE 1. A, The T-VIM targeting (left hemisphere) recreates the anatomy (right hemisphere) in the ventral thalamus. The PT (red) and ML (blue) are tracked. A VIM ROI is then placed 3 mm anterior and medial to PT and ML. The VIM ROI is shown in relation to the final lesion. Comparison of the standard coordinates and tractography coordinates B to D. B, The absolute X-and Y-coordinates. C, the X-coordinate in relation to the ventricle wall. D, the Y-coordinate as a proportion of AC-PC length.
Y = 25% of AC-PC length in front of the PC, and Z = at the AC-PC level). Tremor severity was assessed using clinical tremor rating scale (CRST, subscales A and B). CRST subscale-C and Quality of Life Scale in Essential Tremor (QUEST) scales were used for determination of quality of life. For primary outcome assessment, the recorded videos at baseline and 3 mo were scored by a core group of blinded and independent neurologists. For 6-mo outcomes, the assessment by the study movement disorder neurologists was used. Additionally, data regarding side effects, operative time, and the number of sonications were also collected. For each patient, the postoperative T2-weighted scan was intensity normalized (AFNI, 3dUnifize, National Institutes of Health, Bethesda, Maryland) and coregistered to the preoperative T2 using nonlinear registration methods to account for displacement associated with postoperative edema (FSL, FNIRT, Oxford University, Oxford, United Kingdom). The distance between the VIM ROI target and the lesion epicenter was calculated in all 3 planes. The hyperintense rim corresponding to the necrotic center of the lesion 23 was manually segmented (ITK-Snap software) and the resulting mask was binarized. The segmented, binarized T-VIM ROI was exported from StealthViz R Software (Medtronic Inc) and rigidly aligned to the preoperative T2 scan. The intersection volume between the 2 was calculated. In addition, we used a mask of the thalamus outlined by manual segmentation on preoperative T2 imaging to calculate the distribution of the lesion within the thalamus and sub-thalamic regions.
To validate the deterministic tractography findings we used 2 independent approaches: 1. Lesion localization relative to probabilistic tractography-based thalamic parcellation-The validation of the tractography-based VIM ROI using probabilistic tractography has previously been published. 19 For this analysis, we aimed to study whether the FUS-T lesions also co-localized with VIM identified using probabilistic tractography. Thalamic parcellation based on the likelihood of connectivity to specific cortical masks was used, 24 and VIM was identified based on its connectivity with motor cortex. 25 We chose this approach because it differs from the deterministic tractographybased VIM identification in the choice of tractography methodology (probabilistic vs deterministic tractography) and the approach for localization of VIM ROI (probability of cortical connectivity vs ROI selection relative to the location of PT and ML). The FUS-T lesions were mapped in relation to the thalamic parcellation using probabilistic tractography as described below.
Microstructural changes after FUS-T-Changes in white matter
tracts after FUS-T, specifically the DRT, have previously been correlated with clinical outcomes. 26 We aimed to study whether there were significant microstructural changes within DRT after FUS-T using the tractography-based targeting. The microstructural changes were analyzed using quantitative DWI as described below.
For these analyses, we used a consolidated neuroimaging pipeline based on FSL (FMRIB's software library, FSL). DWIs were corrected for artifacts (eddy currents and motion) and thresholded to exclude skull. We used an ordinary least-squares approach (DTIFIT, FSL) for tensors compuation. The fractional anisotropy (FA) images for each time point (presurgical and 1-yr follow-up) were rigidly coregistered and then nonlinearly aligned to International Consortium for Brain Mapping (ICBM)-152 template space. For lesion localization, the combined lesion intersection map was overlaid with a probabilistic clustering based combined segmentation of the thalamus from ET patients in this cohort. 24 For analyzing the microstructural changes within tracts, the FA values between baseline and long-term follow-up imaging were statistically compared using tract-based spatial statistics (TBSS, FSL; randomize 1-sample paired t-test with 2000 permutations threshold-free cluster enhancement method, FA threshold ≥ 0.2, map thresholded by 1-P > .95).
Only data from patients who completed the follow-up at each visit were analyzed. Statistical analysis was be performed with SPSS (v.22, IBM Corp, Armonk, New York). Descriptive variables were summarized as mean and standard deviation (SD; for continuous variables) and proportions (for categorical variables). The normality of data was first checked using Kolmogorov-Smirnov test and P < .05 was considered statistically significant. The tremor outcomes between pre-and postoperative conditions were compared with paired t-test. The tremor outcomes were also correlated with baseline tremor severity, intraoperative tremor reduction, and lesion size and location (proportion of subthalamic component).
RESULTS

Demographics
From the 16 patients screened, 10 were enrolled and treated (Table 1 ). All patients completed the 3-mo follow-up and 1 patient did not complete 6-mo follow-up due to social circumstances. The mean age of the cohort was 70.8 ± 9.7 yr and 40% were females. The patients reported having tremors for an average of 34.3 yr (SD = 22.1) from symptom onset and 25.8 yr (SD = 18.7) from diagnosis. Seventy percent of patients had a family history of tremors and 80% reported tremors to be alcohol responsive. Patients had typically used several tremor medications (mean 2.5 ± 1.2 medications) without benefit. The mean skull density ratio was 0.54 (SD = 0.1). The tremor severity at its baseline was 59.3 ± 17.3 with a quality of life score of 81.7 ± 17.7.
Procedural Outcomes
Tractography-based VIM targeting was technically feasible in 9 out of 10 patients. The software was not customized for the prospective imaging analysis for the first patient. The coordinates of tractography-based VIM were significantly different from the standard coordinates (3-dimensional distance 3.2 ± 1.9 mm). The anteroposterior coordinate differed significantly between the two targeting approaches (standard: 6.7 ± 0.3 mm and tractography: 7.6 ± 1 mm anterior to PC, P = .02; Figure 1 ). The mean operative time was 78 ± 31.9 min with an average of 13.9 ± 4.5 sonications (Table 2) .
In all 9 patients, therapeutic sonication (>55 • C temperature, 10 s) at the tractography target resulted in >50% intraoperative tremor improvement (68.1 ± 15.5%) in all patients without any motor or sensory side effects. In all patients the peak-temperature voxel was within the VIM ROI with a mean distance of 1.8 ± 1.2 mm from its center. For control of patient-specific tremor, additional lesions were created 1 mm lateral (n = 2 patients, for better control of proximal arm tremor) and 1 mm medial (n = 1 patient, for better control of hand tremor) to T-VIM. 
Lesion Characteristics
The lesion shape and size varied considerably between patients (mean lesion volume 386.1 ± 212.1 mm 3 ) spanning the thalamus and ventral to thalamus (mean lesion volume in subthalamic region 127.1 ± 171.9 mm 3 ). The lesion incorporated 68% (SD, 35.7) of the tractography-based VIM ROI.
Safety Profile-Adverse Events
None of the patients experienced sensory deficits or motor weakness (Table 3) . Three patients developed transient ataxia after treatment, which resolved during follow-up (1-6 mo). There was a trend towards association between lesion size and ataxia (with ataxia: 559.7 ± 302.7 mm 3 vs without ataxia: 311.7 ± 124.1 mm 3 , 2-tailed independent samples t-test P = .09)
Tremor Outcomes
Independent tremor assessment revealed significant improvement in tremor scores at 3 mo: 56% for hand tremor score on the treated side (n = 10, CRST A and B: 18.3 ± 6.9 vs 8.1 ± 4.4, P = .001) and 45% in total tremor score (n = 10, total CRST: 69.1 ± 25.2 vs 38.2 ± 18.9, P = .007; Figure 2 ). The quality of life improved significantly (n = 10, preoperative QUEST: 81.7 ± 17.7 vs postoperative QUEST: 45.3 ± 11.6, P = .000127).
One patient was lost to follow-up at 6 mo. In 9 patients, tremor improvement was maintained at 6 mo (total CRST: 32 ± 15.9; QUEST score: 45.6 ± 10.8)
Predictor of Outcomes
There was a trend towards negative correlation between baseline tremor score and tremor improvement (Pearson's correlation coefficient = -0.63, P = .053). Interestingly, intraoperative tremor reduction was not a good predictor of 3-mo tremor outcome (Pearson's correlation coefficient = -0.05, P = .0023).
Given the heterogeneity in size and shape of FUS-T lesions, we sought to investigate its impact on clinical outcomes. Neither the lesion size, location (subthalamic component), or overlap with DRT or VIM ROI were associated with outcomes. Figure 3 shows the results of clustering-based (K-means algorithm) thalamic parcellation with known cortical connections using probabilistic tractography for all 10 patients. Using this
Lesion Location in Relation to Unbiased Thalamic Parcellation
FIGURE 3. A to C, Lesion location in relation to unbiased thalamic parcellation using probabilistic tractography in axial A, sagittal B, and coronal C planes. The VIM parcellation is shown in green and the lesion in magenta colors. Majority of the lesion is located within thalamus with extension ventral to the thalamus. The color code for thalamic parcellation (inset) includes red (frontal), green (motor), blue (parietal), pink (occipital), copper (temporal), and yellow (insular). D to F, Changes in FA along white matter tracts are shown between preop and follow-up diffusion weighted imaging. TBSS revealed significant changes along the trajectory of DRT in the contralateral cerebellum and superior cerebellar peduncle D, ventral thalamus E, and the thalamocortical projections to the motor cortex F.
unbiased approach, we observed a significant overlap of combined lesion mask with the VIM defined by probabilistic segmentation.
Microstructural Changes in DRT
Using TBSS, we observed significant changes in the microstructure integrity within the cerebellum, superior cerebellar peduncles, ventral thalamus, and primary motor cortex (Figure 3 ). In the cerebellum, significant FA changes were noted in the contralateral dentate and superior cerebellar peduncle. Similarly, FA changes were also noted along the ipsilateral thalamocortical projections to motor cortex. A list of average FA values computed across a representative subset of masks, like superior cerebellar peduncle, ventral thalamus, and primary motor cortex in ICBM space (Oxford thalamic connectivity atlas plus Juelich atlas, both available in the FSL suite), is available in Table 4 .
DISCUSSION
In this report, we successfully used prospective VIM targeting with deterministic tractography in ET patients undergoing FUS-T. This approach allowed us to avoid neurological deficits associated with off-target ablation of PT, ML, or Vc while achieving 56% tremor reduction on the treated side. Also reported was a significant reduction in the total number of sonications 13 and procedure duration. These findings were also validated with probabilistic tractography and corresponding microstructural changes in the fiber connections of VIM after FUS-T.
The VIM nucleus is the therapeutic target for tremor surgery. 27 Histologically, this nucleus is about 4 × 4 × 6 mm in size and also not distinctly visible on structural MRI due to the lack of a lamina to differentiate it from other nuclei within the ventral thalamus. 28 VIM receives input from the contralateral, and to a lesser extent from the ipsilateral, dentate nucleus through the DRT and it projects mainly to the motor and premotor cortex. 29, 30 Recent investigations have also identified the DRT as a potential neuroimaging predictor of good outcomes after tremor surgery. 31, 32 Therefore, visualization of the DRT is important to capture the interindividual variability in location of the VIM 19, 33 and determination of therapeutic target during tremor surgery. 34 Diffusion tensor imaging (DTI) is a noninvasive tool for visualizing white matter pathways in the human brain. 35 Although transformative, this technology has some disadvantages due to the high sensitivity of the echo-planar imaging for magnetic susceptibility artifacts and long acquisition time required for highresolution imaging. We developed a framework to address some of these limitations and improve the anatomic accuracy of DTI. 19 This methodology for tractography-based VIM targeting was useful for DBS surgery and correlated well with intraoperative physiology. 19 In this report, we used this framework, for the first time, to prospectively target the VIM during FUS-T in patients with ET. Here, we used tractography to prospectively delineate the therapeutic target solely based on the individual pattern of white matter connectivity without considering the indirect coordinates based on formulaic or atlas-based methods. For accurate targeting, we carefully selected the VIM ROI in relation to PT and ML. The visualization of the DRT was an additional confirmation of accurate localization. In short-term, we were able to show 2 major advantages: lesser chance of unwanted side effects, and quick and precise identification of the VIM for FUS-T reflected in the reduced number of sonications required to achieve therapeutic ablation 13 with shorter duration of treatment. Notably, the sensory and motor deficits were reported in up to one-third of patients in the published literature. 13 Although the surgical times were not reported in recent FUS-T trials, our surgical time compares favorably with the historical published data from conventional "open" thalamotomy. 36 The occurrence of ataxia, however, was similar to other published studies. 13 We observed it in 3 out of 10 patients with resolution between 1 and 6 mo and a trend towards its association with larger lesions.
FUS-T has previously been demonstrated to be effective in treating unilateral tremor and improve patients' quality of life in previous trials. 13, 37 Ultrasound can temporarily and reversibly inhibit neuronal activity in specific subcortical areas with high accuracy 38, 39 allowing for a limited physiological exploration during FUS-T. However, detailed mapping of the target nucleus can be extremely time consuming and inaccurate. We found a poor correlation between intraoperative and 3-mo tremor improvement. Although the 3-mo tremor improvement with tractography-based targeting is comparable with the previously published reports, 13, 18, 37, 40 there is still significant heterogeneity in degree of tremor reduction (at 3 mo tremor reduction varied between 36% and 80%). Several potential reasons may includepatient-related factors, targeting accuracy, and lack of a standard treatment endpoint. We report a trend towards suboptimal tremor control in patients with severe tremor at baseline. This finding needs further validation in larger studies. We did not find a relationship between the lesion size, location (thalamic vs subthalamic or relative to VIM ROI and DRT), and clinical outcomes, larger studies are required to further understand this relationship. We found the volume of the FUS-T lesions to be highly variable, eg in this cohort the lesion volumes ranged from 115 to 819 mm 3 (mean: 386.1 mm 3 , SD: 212.1 mm 3 ). In contrast to the radiofrequency ablations, where the electrode size and current intensity determine lesion size, 41 the lesion size after FUS-T depends on the skull and local tissue characteristics in addition to the incident energy and duration of exposure, eg patient numbers 1 and 7 in this series, having received a similar peak energy sonications (6507 and 7149 Joules vs 6500 and 6000 Joules) for similar durations (10 s each vs 10 and 13 s), attained lesions with significantly different sizes (530 mm 3 vs 227 mm 3 ). These patients had different skull density ratios (0.67 vs 0.58). Other factors influencing lesion characteristics include technical (eg varying degree of lesion extension below the intercommissural plane), effect of different sonication numbers or configuration (eg stacked lesions), and technology related (eg inaccuracy due to MRI table movement between clinical testings, use of 2-D MR thermometry).
Limitations
We have discussed the limitations of streamline tractography before, 19 however, it is worth noting that this approach is unable to resolve crossing fibers. Despite these limitations, deterministic tractography algorithms produce fewer false positive results, albeit with a loss of sensitivity, and may be more suitable for surgical planning. 42 Future FUS planning systems should include advanced deterministic tractography algorithms that can resolve crossing fibers 43 to better visualize the white matter anatomy in all 3 planes. Although we demonstrate the utility of prospective tractography-guided VIM targeting for improving the side effects profile of FUS-T, its overall impact remains to be determined in larger cohorts with long-term follow-up. A lack of a control group and small sample size limit our ability to make conclusions regarding the safety and efficacy of tractography-based methods and to compare those to standard targeting methods. Currently, the determination of treatment endpoint is quite subjective (eg the number of therapeutic sonications required for a long-term tremor suppression is unknown). In the future, the need to pursue additional therapeutic sonications may require an intraoperative physiological feedback to better define a treatment endpoint especially since intraoperative tremor reduction may not be reliable for this purpose.
CONCLUSION
Prospective tractography-based VIM targeting for tremor surgery is feasible. The short-term clinical results from this cohort establish initial safety and efficacy. Long-term tremor efficacy outcomes are desirable to further assess the usefulness of this technique. Future studies should incorporate larger cohorts with controls to definitively compare this targeting method with standard targeting.
